Skip to content

support@abbonews.com

Menu

US Markets
Business
Technology
News
Featured
Press Release
Subscribe Now For Free

US Markets
Business
Technology
News
Featured
Press Release
Subscribe Now For Free

US Markets
Business
Technology
News
Featured
Press Release
Subscribe Now For Free

NASDAQ: EVO

Evotec Receives €2 Billion Buyout Offer from Halozyme Therapeutics

Edward Cooke / 14 November 2024

On Thursday, Halozyme Therapeutics (NASDAQ: HALO) said it has proposed to buy German drug developer Evotec (NASDAQ: EVO) for about […]

Evotec Receives €2 Billion Buyout Offer from Halozyme Therapeutics Read More »

Evotec (NASDAQ: EVO) Stock Surges After Triton Acquires Nearly 10% Stake, Mulls Buyout Bid

Mary Lee / 11 November 2024

Shares in Evotec (NASDAQ: EVO) soared 22% on Monday after private equity firm Triton confirmed a close to 10% stake

Evotec (NASDAQ: EVO) Stock Surges After Triton Acquires Nearly 10% Stake, Mulls Buyout Bid Read More »

Novo Nordisk

Evotec and Novo Nordisk (NYSE: NVO) Form Technology Development Partnership for Stem Cell Therapies

Edward Cooke / 26 September 2024

Evotec (NASDAQ: EVO), the German drug and development company, has entered into a technology development partnership with Novo Nordisk (NYSE:

Evotec and Novo Nordisk (NYSE: NVO) Form Technology Development Partnership for Stem Cell Therapies Read More »

Company

Become A Contributor

Categories

Legal

Editorial Policy

Top Tech Stocks 2024

Top Bank Stocks 2024

Worst Stocks 2024

We Are Licensed Partners Of Reuters

Copyright © 2024 abbonews.com